Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Gynecologic Oncology
•
Cervical Cancer
How would you approach unresectable pelvic side wall recurrence in cervical cancer with previous definitive chemoradiation?
Would you consider SBRT or brachytherapy?
Answer from: Radiation Oncologist at Community Practice
I would start with palliative chemo and if good response, plan for SBRT for residual disease with the dose based on OAR.
Comments
Radiation Oncologist at UAB Department of Radiation Oncology
I agree with the above comments. This is one of th...
Radiation Oncologist at Baylor College of Medicine
What dose constraints have you been following for ...
Radiation Oncologist at Varian Medical Systems/Allegheny health network
Ling et al., PMID 31150869
Radiation Oncologist at Emeritus Professor
The definition of unresectable pelvic sidewall rec...
3340
3344
3346
3372
Sign In
or
Register
to read more
8198
Related Questions
Do you have concerns about the validity of the INTERLACE data, considering the long study recruitment period (10 years) and evolution of radiation techniques that have occurred during that time frame?
In patients getting concurrent chemo-immunotherapy for locally advanced cervix cancer, would you hold immunotherapy during the 2.5-3 weeks of brachytherapy?
How would you utilize brachytherapy boost in addition to EBRT for HPV-dependent invasive squamous cell carcinoma present as a large pelvic side wall mass, presumed to be of cervix primary, albeit the negative biopsies of the cervix?
Is there a role for definitive radiotherapy in patients with de-novo metastatic cervical cancer after achieving complete response with chemo-immunotherapy per KEYNOTE-826?
What are some considerations for planning T&O brachytherapy in a patient with bilateral hip replacements, where it is difficult to delineate disease on MRI and even surrounding structures on CT?
In patients treated with the KEYNOTE A-18 regimen who later recur, would you rechallenge with immunotherapy again?
Does being on maintenance pembrolizumab change how you manage patients with partial metabolic response on PET/CT 3 months after chemoradiation for cervical cancer?
For vaginal cuff recurrence of an endometrial cancer, when do you utilize a multichannel cylinder versus single channel cylinder if a patient has <5 mm residual disease after EBRT?
How do you approach adjuvant radiation recommendations for low-risk endometrial cancer in which the patient was unable to undergo pelvic sentinel node mapping?
How do you approach radiation treatment of extramammary Paget's disease of vulva, diffusely involving the urothelium and the periurethral glands?
I agree with the above comments. This is one of th...
What dose constraints have you been following for ...
Ling et al., PMID 31150869
The definition of unresectable pelvic sidewall rec...